Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: LENSAR (NASDAQ:LNSR), Modular Medical (NASDAQ:MODD), NeuroOne Medical Tech (NASDAQ:NMTC), Femasys (NASDAQ:FEMY) and Vivani Medical (NASDAQ:VANI).
Lucid Diagnostics has a consensus price target of $3.88.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.98 last updated October 31, 2024 at 3:34 PM EDT.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.